Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Hormone receptor positive malignant neoplasm of breast (Disease Or Phenotype)

Medcin:MEDCIN:356909

Id:7fcafd5e-8000-54f2-8ca2-14506540d22a

Results found

Linked to

	Label	Description
	Palbociclib; Ibrance indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Megestrol indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Exemestane indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Oxymesterone indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	testosterone indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Abemaciclib indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Letrozole indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ribociclib indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Megestrol Acetate indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Everolimus indication Hormone receptor positive malignant neoplasm of breast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Palbociclib; Ibrance indication Hormone receptor positive malignant neoplasm of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Megestrol indication Hormone receptor positive malignant neoplasm of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Exemestane indication Hormone receptor positive malignant neoplasm of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Oxymesterone indication Hormone receptor positive malignant neoplasm of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

testosterone indication Hormone receptor positive malignant neoplasm of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Abemaciclib indication Hormone receptor positive malignant neoplasm of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Letrozole indication Hormone receptor positive malignant neoplasm of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Ribociclib indication Hormone receptor positive malignant neoplasm of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Megestrol Acetate indication Hormone receptor positive malignant neoplasm of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Everolimus indication Hormone receptor positive malignant neoplasm of breast

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.